|
Biopsy-based diagnostic platform for determining subtype and malignancy of renal cancers
Abstract
USC scientists have built a predictive cancer classification model using 697 DNA methylation profiles that can distinguish between six different sub-types of kidney tumors. They have validated the DNA methylation dependent classifier in 272 ex-vivo needle...
|